title: Off-patent oral oncology drugs for kids (O3K FP7-project): from bedside to PUMA.
authors.affiliation: Pharmacology and Drug Analysis Department, Institut de cancérologie Gustave Roussy, 114, rue Edouard Vaillant, 94805 Villejuif cedex, France. angelo.paci@igr.fr
authors.forename: Angelo
authors.initials: A
authors.lastname: Paci
authors.forename: Gilles
authors.initials: G
authors.lastname: Vassal
mesh_terms: D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage*; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives; D016568:Drugs, Generic / Q000008:administration & dosage*; D005062:European Union; D006801:Humans; D007880:Legislation, Drug; D004364:Pharmaceutical Preparations / Q000592:standards; D000077204:Temozolomide
chemical_list: D000970:Antineoplastic Agents; D016568:Drugs, Generic; D004364:Pharmaceutical Preparations; D003606:Dacarbazine; D003520:Cyclophosphamide; D000077204:Temozolomide